Researching and developing new methodologies towards personalised and improved radiation dosimetry

Radiopharmaceuticals administered to individuals give origin to deposition of energy (tissue absorbed dose) with biological effects that need to be measured and accounted for during the preparation of radioligands to be administered. We are engaged in the investigation and development of new methods and algorithms that will enable the calculation and personalization of radiotracers to be administered to patients and mapping their corresponding absorbed doses.